SCHEMBL25005167

SCHEMBL25005167

CCS(=O)(=O)Nc1ccccc1Nc1nc(Cl)ncc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 2/20 0.43
PSIP1 O75475 1/20 0.42
GLO1 Q04760 1/20 0.40
PTGS1 P23219 2/20 0.39
PTGS2 P35354 2/20 0.39
EGFR P00533 1/20 0.38
PKMYT1 Q99640 1/20 0.37
AURKA O14965 1/20 0.37
NR3C1 P04150 1/20 0.36
CDK7 P50613 1/20 0.36
CDK9 P50750 1/20 0.36
MET P08581 1/20 0.36
ALK Q9UM73 1/20 0.36
PIN1 Q13526 1/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PIK3CG P48736 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31147615 1.00 BRD4 (0.43) BRD4PSIP1GLO1PTGS1PTGS2
SCHEMBL30942594 0.91 BRD4 (0.45) BRD4GLO1PTGS1PTGS2EGFR
SCHEMBL27237987 0.91 BRD4 (0.45) BRD4GLO1PTGS1PTGS2EGFR
SCHEMBL602490 0.88 ALK (0.46) PSIP1GLO1EGFRCDK7CDK9
SCHEMBL38655775 0.88 ALK (0.46) PSIP1GLO1EGFRCDK7CDK9
SCHEMBL31147654 0.88 ALK (0.46) PSIP1GLO1EGFRCDK7CDK9
SCHEMBL30942610 0.87 GLO1 (0.52) GLO1PTGS1PTGS2EGFRMET
SCHEMBL1076995 0.87 GLO1 (0.52) GLO1PTGS1PTGS2EGFRMET
SCHEMBL10074538 0.86 GLO1 (0.55) PSIP1GLO1AURKAALKALDH1A1
SCHEMBL38657160 0.86 MEN1 (0.48) PSIP1GLO1EGFRCDK7CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4382514-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT Korea Research Institute of Chemical Technology (KR) 2024-06-12 EP disclosed
WO-2023014022-A1 PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER COMPRISING SAME AS ACTIVE INGREDIENT 한국화학연구원 2023-02-09 WO disclosed